As a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, Mounjaro works by enhancing insulin secretion, suppressing glucagon release, slowing gastric emptying, and reducing appetite
In that report, the incidence of pancreatic cancer was also 2.9 and 2.7 times greater with exenatide and sitagliptin, respectively, compared to other oral antidiabetic medications
These findings open new possibilities for treating conditions beyond weight and blood sugar management
No , the FDA has not approved a generic version of Ozempic
Eligibility criteria include specific BMI thresholds, and participants must agree to randomization, meaning they may receive placebo